Moreover, CD4-positive T cell clones in peripheral blood proliferate in melanoma patients after treatment with an anti-CTLA-4 antibody, and these CD4-positive T cell clones are enriched in corresponding tumors. The gene discussed is CD4; the disease is melanoma.